Replies to post #119642 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Anavex Announcement, Three Upcoming Trials of Anavex 2-73

http://www.anavex.com/about-us/overview/

The Company is in preparation for ANAVEX™ 2-73 for a Phase 2/3, placebo-controlled trial in [Trial One, this fall, for one year.] Alzheimer’s disease as well as a Phase 2, placebo-controlled trial in Rett syndrome, [Trial Two, for 3 months, beginning this fall.] for which the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for ANAVEX™ 2-73 and a Phase 2, placebo-controlled trial in Parkinson’s disease. [Trial Three, starting this fall.]

Two short, 3-month trials sometime this autumn, Rett syndrom and Parkinson’s disease . A big year-long double-blind Alzheimer’s trial, starting this fall or early 2081.

Exact dates are unknown, not yet announced or perhaps not even determined.